Peptides
Ben Synth explores GLP-1 receptor agonists—the peptide class behind semaglutide and tirzepatide—tracing their origin from Gila monster venom to transformative medications backed by decades of rigorous trials. He contrasts this gold-standard evidence with the unproven compounds flooding the peptide market, revealing the critical gap between real science and hype. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
4 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Peptides!